Kiwifruit Powder as a Precision Prebiotic Ingredient
Most kiwifruit-derived ingredients on the market are sold on the strength of a single compound: a fiber isolate or an extracted polyphenol. Livaux® takes the opposite approach: it’s made from gently processed New Zealand gold kiwifruit, retaining the fruit’s natural matrix of dietary fibre—including pectin—polyphenols, vitamins and minerals. For formulators evaluating prebiotic ingredients, that distinction matters more than it might first appear, and it’s backed by a clinical and mechanistic data set that’s worth walking through.
Whole-Fruit vs. Isolated Fiber
Simple-structured prebiotics such as FOS, GOS and inulin tend to be fermented rapidly by gut bacteria, with much of that fermentation occurring in the early colon. That speed is also their limitation: rapid fermentation is a well-documented driver of the gas and bloating that make these ingredients hard to dose at meaningful levels.
Livaux®’s kiwifruit pectin is structurally different: it is one of the most complex polysaccharide structures found in nature, requiring a broad range of bacterial enzymes to break down. That complexity means slower, more distributed fermentation further along the colon.
| FOS, GOS, inulin | Livaux® | |
|---|---|---|
| Fermentation speed | Rapid | Slow, sustained |
| Site of fermentation | Mainly early colon | Further along the colon |
| Typical effective dose | 3-20g+ | 600mg |
| Tolerability | Gas/bloating common at effective doses | Well tolerated at 600mg |
Livaux’s Clinical Profile
The core claim behind Livaux® is its effect on Faecalibacterium prausnitzii (F. prausnitzii), one of the most important beneficial bacteria in the human gut and a major producer of butyrate, a short-chain fatty acid that fuels the cells lining the colon and supports gut health. F. prausnitzii is notoriously difficult to produce as a stable probiotic since it’s highly oxygen-sensitive, which is why a prebiotic capable of promoting its growth is a meaningfully different proposition from a generic fiber ingredient.
Two human trials support this:
- McKeen et al., 2025: 600mg/day of Livaux® for 28 days produced a statistically significant increase in F. prausnitzii relative abundance in otherwise healthy adults with occasional constipation.
- Blatchford et al., 2017: 2.4g/day for 28 days resulted in a statistically significant two-fold increase in F. prausnitzii relative abundance in adults with functional constipation.
In the M-SHIME® artificial gut model, a Livaux®-containing synbiotic combination produced significant increases in butyrate across all three colon regions tested (proximal, transverse and distal). These increases were not seen when the same probiotic blend was tested without the Livaux® prebiotic blend, indicating the effect was driven by the fermentation of the prebiotic rather than by the probiotic blend alone.
Formulation Considerations
Three things matter most for formulators evaluating Livaux®:
- Low effective dose. 600mg/day is a convenient inclusion level across capsules, sachets and powder formats, and sits well below the 3-20g doses often needed for isolated prebiotic fibers to show an effect.
- Tolerability. The slow, sustained fermentation profile is consistent with the reduced gas and bloating seen in clinical studies, a meaningful formulation advantage over simple-structured prebiotics at comparable efficacy.
- Synbiotic pairing. Livaux® has been shown to support the growth of several commercially available probiotic strains at doses as low as 25mg per billion CFU, including Bifidobacterium lactis HN019 (+115%) and Lactobacillus rhamnosus HN001 (+111%).
For formulators building a broader digestive-comfort proposition rather than a prebiotic-only product, Livaux®’s precision microbiome support pairs naturally with Actazin®’s clinically-studied digestive regularity science. Together, the combination covers both microbiome diversity and bowel regularity within a single formulation strategy.
Sourcing at Scale
Livaux® is processed from New Zealand-grown gold kiwifruit using Anagenix’s gentle proprietary processing, part of the Target Bio-Lock™ freeze-drying platform used across the Anagenix ingredient portfolio, which is designed to preserve the fruit’s full nutrient and bioactive profile through to the finished powder. Anagenix supplies Livaux® to nutraceutical and supplement manufacturers through its global distribution network, with technical and regulatory support available for formulators developing synbiotic, digestive-health, or microbiome-focused products.
Frequently Asked Questions
What is Livaux and how is it different from other prebiotic ingredients?
Livaux® is a whole gold kiwifruit powder, not an isolated fiber extract. It retains the fruit’s natural matrix of dietary fiber, pectin, polyphenols, vitamins and minerals. Its complex kiwifruit pectin supports slower fermentation further along the colon and helps deliver associated polyphenols deeper into the gut, where they are transformed into bioactive compounds.
What is the effective dose of Livaux?
600mg of Livaux® per day has been shown to significantly increase Faecalibacterium prausnitzii abundance from baseline, offering a low inclusion level compared with the 3–20g commonly studied for isolated prebiotic fibers.
Does Livaux cause the bloating associated with other prebiotics?
Livaux®’s complex kiwifruit pectin supports slower fermentation further along the colon, a fermentation profile consistent with the good tolerability seen in its clinical trials. Improvements in digestive comfort have also been reported from baseline in the clinical studies.
Can Livaux be combined with probiotics in a synbiotic formulation?
Yes. Livaux® supports the growth of several commercial probiotic strains at doses as low as 25mg per billion CFU. Its low inclusion rate and low water activity make it well suited to synbiotic formulations.
